Omikron Outbreak, DGNS Conducts up to 1,000 Covid-19 Tests a Day

PT Diagnos Laboratorium Utama Tbk (DGNS) as one of the clinical laboratory issuers has a molecular laboratory since the beginning of the Covid-19 pandemic. This makes DGNS one of the leading laboratories in conducting tests related to covid-19.

The covid-19 testing carried out by DGNS has increased along with the increase in positive cases of covid-19 caused by the rampant omikron variant that is sweeping the country. DGNS Corporate Secretary Fanfan Riksani stated that armed with a wide range of services throughout Indonesia, his party was able to run an average of more than 1,000 tests per day during the surge in covid-19 patients due to the omikron variant.

In addition, DGNS provides a special covid-19 test to detect omikron variants by conducting a PCR (polymerase chain reaction) examination using the SGTF (S-Gene target failure) method. The reason is, many Indonesians have contracted covid-19 with the omikron variant.

Surviving to maintain the quality of the examination is a challenge for DGNS during the surge in covid-19 cases. Especially with all the limitations that exist due to increasingly strict health protocols. "There are many efforts that DGNS has tried, such as providing the best service from receiving patients to providing appropriate and fast test results, which continues to be the main focus of DGNS to continue to succeed in becoming the leading laboratory in serving covid-19 testing," he explained. (RO/OL-14)

Source: https://mediaindonesia.com/humaniora/468706/omikron-merebak-dgns-lakukan-sampai-1000-tes-sehari